Company Filing History:
2 out of 53 
2 out of 9 
2 out of 102 
Years Active: 2002-2023
Title: Claire Elizabeth Lewis: Innovator in Oncolytic Virus Research
Introduction
Claire Elizabeth Lewis is a prominent inventor based in Sheffield, GB. She has made significant contributions to the field of cancer treatment through her innovative research. With a total of 4 patents, her work focuses on the use of oncolytic herpes simplex virus infected cells in medical applications.
Latest Patents
One of her latest patents involves a monocyte, monocyte-derived cell, or macrophage infected with an oncolytic herpes simplex virus. This invention discloses the potential uses of such infected cells in the treatment of diseases, particularly cancer. The implications of her research are profound, offering new avenues for therapeutic interventions.
Career Highlights
Throughout her career, Claire has worked with notable companies such as Oxford Biomedica Limited and Virttu Biologics Limited. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative treatments.
Collaborations
Claire has collaborated with esteemed colleagues, including Joe Conner and Munitta Muthana. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Claire Elizabeth Lewis stands out as a key figure in the realm of oncolytic virus research. Her innovative patents and collaborations highlight her commitment to advancing cancer treatment. Her contributions continue to inspire future research in this critical field.